Everett Harris & Co. CA Takes $2.14 Million Position in Cardinal Health, Inc. $CAH

Key Points

• Everett Harris & Co. CA acquired 8,993 Cardinal Health shares worth approximately $2.14 million during the second quarter. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, beating estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company maintained fiscal 2027 EPS guidance of $12.40–$12.60.
• Analysts remain positive, with 15 Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $265.93, above the reported share price of $234.92. Cardinal Health also announced a quarterly dividend of $0.5158 per share.

Everett Harris & Co. CA purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,993 shares of the company's stock, valued at approximately $2,136,000.

Several other institutional investors also recently added to or reduced their stakes in CAH. Integrated Wealth Concepts LLC raised its position in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock valued at $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of Cardinal Health during the 2nd quarter worth $1,935,000. Cerity Partners LLC increased its stake in shares of Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock valued at $6,792,000 after buying an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC raised its holdings in shares of Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock valued at $1,736,000 after acquiring an additional 2,646 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $234.92 on Friday. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30. The business has a fifty day moving average price of $230.30 and a 200 day moving average price of $217.14. The stock has a market capitalization of $54.64 billion, a P/E ratio of 32.49, a price-to-earnings-growth ratio of 1.37 and a beta of 0.49.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm's quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 12.52 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health's payout ratio is presently 28.49%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CAH shares. Bank of America upped their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Evercore reissued an "outperform" rating and set a $270.00 target price on shares of Cardinal Health in a research report on Wednesday. UBS Group boosted their price target on shares of Cardinal Health from $274.00 to $280.00 and gave the company a "buy" rating in a report on Wednesday. Citigroup upped their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a research report on Wednesday. Finally, Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $265.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source